R1	Has_value Arg1:T1 Arg2:T2	
R2	AND Arg1:T4 Arg2:T3	
R3	Has_temporal Arg1:T3 Arg2:T5	
R4	Has_value Arg1:T6 Arg2:T7	
R5	Has_qualifier Arg1:T11 Arg2:T10	
R6	Has_value Arg1:T8 Arg2:T9	
R7	AND Arg1:T13 Arg2:T8	
R8	AND Arg1:T13 Arg2:T11	
R9	Has_temporal Arg1:T11 Arg2:T12	
R10	Has_qualifier Arg1:T15 Arg2:T14	
R11	Has_qualifier Arg1:T15 Arg2:T16	
R12	Has_multiplier Arg1:T18 Arg2:T17	
*	OR T15 T18
R13	Has_multiplier Arg1:T19 Arg2:T25	
R14	Has_multiplier Arg1:T20 Arg2:T26	
R15	Has_multiplier Arg1:T21 Arg2:T27	
R16	Has_multiplier Arg1:T22 Arg2:T28	
R17	Has_multiplier Arg1:T23 Arg2:T29	
R18	Has_multiplier Arg1:T24 Arg2:T30	
R19	Has_multiplier Arg1:T31 Arg2:T32	
R20	Subsumes Arg1:T15 Arg2:T19	
T1	Person 0 3	Age
T2	Value 6 11	18-65
T3	Condition 27 52	major depressive disorder
T4	Measurement 66 81	DSM-IV criteria
T5	Temporal 92 107	lasted >8 weeks
T6	Measurement 109 114	MADRS
T7	Value 121 142	score of 18 or higher
T8	Measurement 203 208	MADRS
T9	Value 183 195	score of >18
T10	Qualifier 213 223	first-line
T11	Drug 224 238	antidepressant
T12	Temporal 249 258	of 4 week
T13	Observation 157 179	responded inadequately
T14	Qualifier 284 292	standard
T15	Drug 293 307	antidepressant
T16	Qualifier 321 332	monotherapy
T17	Multiplier 351 352	2
T18	Drug 353 368	antidepressants
T19	Drug 371 383	escitalopram
T20	Drug 399 409	fluoxetine
T21	Drug 424 437	paroxetine CR
T22	Drug 452 462	sertraline
T23	Drug 479 490	mirtazapine
T24	Drug 506 516	duloxetine
T25	Multiplier 385 396	10 - 20mg/d
T26	Multiplier 410 421	20 - 40mg/d
T27	Multiplier 438 449	25 - 50mg/d
T28	Multiplier 463 476	100 - 150mg/d
T29	Multiplier 492 503	15 - 45mg/d
T30	Multiplier 518 529	30 - 60mg/d
T31	Drug 534 548	venlafaxine ER
T32	Multiplier 549 560	150-225mg/d
